Top Markets
#1 Celer Network Celer Network +49.10%
#2 Gravity Gravity +24.44%
#3 Galxe Galxe +23.88%
#4 ICON ICON +13.39%
#5 MemeCore MemeCore +13.25%
#6 Cartesi Cartesi +12.87%
#7 Zilliqa Zilliqa +10.95%
#8 Genius Genius +10.65%
#9 Ontology Gas Ontology Gas +9.33%
#10 CyberDEX CyberDEX +7.13%
Coin of the day
Celer Network Celer Network
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Clasificación en acciones #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Precio por acción
$0.1559364
Última sincronización: 2026-09-18
Capitalización bursátil
$195.17K
Cambio (1 día)
6.60%
Cambio (1 año)
-30.91%
País
GB
Comercio Fusion Antibodies plc (FAB)

Categoría

Healthcare
Historial del precio de la acción de Fusion Antibodies plc (FAB)
Precio más alto de cierre: $0.15 el 2026-09-01

Precio más bajo de cierre: $2.40 el 2017-12-01
Historial del precio de la acción de Fusion Antibodies plc desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -10.83%
2025 153.72%
2024 39.11%
2023 -88.99%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $509.53 32.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $991.92 34.63%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $154.28 511.26%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.40 -5.68%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $708.28 3.70%
CH